Clinical Trials Logo
NCT number NCT03498170
Study type Interventional
Source Mereo BioPharma
Contact William Moore, BSc
Phone +44 3330 237300
Email enquiries@mereobiopharma.com
Status Recruiting
Phase Phase 1
Start date March 19, 2018
Completion date May 9, 2018

Clinical Trial Summary

An Open-label, 2-period, Single-sequence, Crossover Study to Evaluate the Effect of Multiple Oral Dosing of Itraconazole on BCT197 Systemic Exposure in Healthy Male Participants.


Clinical Trial Description

This will be an open label study conducted in healthy male participants at a single centre. Each participant will participate in a screening visit and 2 study periods. At the first study period, all participants will receive a single dose of BCT197 and at study period 2, all participants will receive 14 daily doses of itraconazole and a single dose of BCT197.


Study Design


Related Conditions & MeSH terms